# Fiasp

NDC: 0169-3206
Generic name: insulin aspart
Labeler / Manufacturer: Novo Nordisk
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION
Routes: SUBCUTANEOUS
Marketing started: 20171020

FDA application: BLA208751

## Active ingredients

- INSULIN ASPART: 100 [iU]/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0169-3206"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0169-3206
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=834e7efc-393f-4c55-9125-628562a8a5cf